Raily Aesthetic Medicine International Holdings Limited (02135.HK)

Raily Aesthetic Medicine International Holdings Ltd. is an investment holding company, which engages in the provision of aesthetic medical services and consulting services. The company is headquartered in Hangzhou, Zhejiang and currently employs 289 full-time employees. The company went IPO on 2020-12-28. The firm's main business is to provide customers with aesthetic medical services, including aesthetic surgery services, minimally-invasive aesthetic services and aesthetic dermatology services. The firm operates its businesses through three business segments. The Aesthetic Medical Services segment comprises principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others. The Consulting Services segment comprises principally management consulting services. The Aesthetic Medical Equipment Products segment comprises principally sales of collagen injection products, surgical implants and aesthetic medical skincare products. The firm mainly conducts its businesses within domestic market.